Company Filing History:
Years Active: 2016-2021
Title: The Innovative Contributions of Gayle L. Olson
Introduction
Gayle L. Olson is a notable inventor based in Galveston, Texas, recognized for her significant contributions to the field of optoacoustic diagnostic systems. With a total of four patents to her name, Olson has made strides in medical technology that enhance the ability to measure critical physiological parameters.
Latest Patents
Olson's latest patents focus on systems and methods for measuring oxygenation and hemoglobin concentration. These optoacoustic diagnostic systems include a console unit and a handheld probe. The console unit is equipped with a controller, a processor, a photodiode array, an acoustic processing subsystem, and a cooling subsystem. The handheld probe directs light signals from the photodiode array to patient tissue, utilizing different wavelengths based on the physiological parameter of interest. Additionally, the probe features an acoustic transducer that captures acoustic signals generated in response to the directed light signals. Notably, the probe can be directed to the skull of a fetus within the uterus during labor, allowing for accurate determination of blood oxygenation. This capability is crucial in assessing whether a caesarian section is necessary.
Career Highlights
Throughout her career, Gayle L. Olson has worked with esteemed organizations, including the University of Texas System and Noninvasix, Inc. Her work has significantly impacted the medical field, particularly in non-invasive diagnostic techniques.
Collaborations
Olson has collaborated with notable professionals in her field, including Rinat O. Esenaliev and Donald S. Prough. These collaborations have furthered her research and development efforts in optoacoustic technologies.
Conclusion
Gayle L. Olson's innovative work in optoacoustic diagnostic systems exemplifies her commitment to advancing medical technology. Her patents reflect a dedication to improving patient care through precise measurement techniques.